Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol target-controlled infusion algorithm accuracy study in children undergoing major surgery
ACTRN12610000693022Phase 3Completed
- Sponsor
- The Royal Children's Hospital
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of propofol (2 arms), sponsored by The Royal Children's Hospital. Primary endpoint: Accuracy of pediatric pharmacokinetic algorithms for propofol. Started Nov 2010; status: completed.
02
Drugs
propofol
Beyond the preview
Go deeper on ACTRN12610000693022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000693022.